A detailed history of Crux Wealth Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Crux Wealth Advisors holds 4,242 shares of JNJ stock, worth $659,206. This represents 0.37% of its overall portfolio holdings.

Number of Shares
4,242
Previous 5,632 24.68%
Holding current value
$659,206
Previous $815 Million 13.63%
% of portfolio
0.37%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

SELL
$142.06 - $167.7 $197,463 - $233,102
-1,390 Reduced 24.68%
4,242 $704 Million
Q4 2024

Feb 13, 2025

BUY
$143.34 - $165.86 $807,290 - $934,123
5,632 New
5,632 $815 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Crux Wealth Advisors Portfolio

Follow Crux Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crux Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Crux Wealth Advisors with notifications on news.